Top Qs
Timeline
Chat
Perspective
French ship Polyphème (1817)
Ship of the line of the French Navy From Wikipedia, the free encyclopedia
Remove ads
Polyphème was a 4th rank, 74-gun petite Téméraire-class ship of the line built for the French Navy during the 1810s. Completed in 1818, she was captured by the Netherlands while still under construction.
Remove ads
Background and description
Summarize
Perspective
Polyphème was one of the petit modèle of the Téméraire class that was specially intended for construction in some of the shipyards in countries occupied by the French, where there was less depth of water than in the main French shipyards.[1] The ships had a length of 53.97 metres (177 ft 1 in), a beam of 14.29 metres (46 ft 11 in) and a depth of hold of 6.9 metres (22 ft 8 in). The ships displaced 2,781 tonneaux and had a mean draught of 6.72 metres (22 ft 1 in). They had a tonnage of 1,381 port tonneaux. Their crew numbered 705 officers and ratings during wartime. They were fitted with three masts and ship rigged.[2]
The muzzle-loading, smoothbore armament of the Téméraire class consisted of twenty-eight 36-pounder long guns on the lower gun deck and thirty 18-pounder long guns on the upper gun deck. The petit modèle ships ordered in 1803–1804 were intended to mount sixteen 8-pounder long guns on their forecastle and quarterdeck, plus four 36-pounder obusiers on the poop deck (dunette). Later ships were intended to have fourteen 8-pounders and ten 36-pounder carronades without any obusiers, but the numbers of 8-pounders and carronades actually varied between a total of 20 to 26 weapons.[2]
Remove ads
Construction and career
Polyphème was ordered in October 1812[3] and laid down in December 1812 in Amsterdam. The ship was seized by the Dutch after the French evacuated Amsterdam in December 1813, renamed as Holland, and launched in July 1817. She was commissioned in the Royal Netherlands Navy the following year.[4] Holland was broken up in 1832.[3]
Citations
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads